Position in LLY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$314,087,555
+$92,846,087 QoQ
Shares Held
261,864
+8.9% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
1.55%
of 13F equity value
Holder Rank
#205
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Sep 30, 2022CallValue
$1,293
CallShares
4
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026M&T Bank Corp holds $1,400,301,000 across 15 Drug Manufacturers - General names. LLY ranks #2 (22.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,544,780 | $392,327,766 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
261,864 | $314,087,555 | |
| 3 | ABBV |
AbbVie Inc.
|
947,647 | $238,465,884 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,434,057 | $184,276,321 | |
| 5 | PFE |
Pfizer Inc
|
2,717,196 | $65,430,073 | |
| 6 | AMGN |
Amgen Inc
|
162,127 | $58,709,426 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
759,648 | $43,770,913 | |
| 8 | NVS |
Novartis AG
|
183,359 | $28,736,020 |
All Filings in LLY
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $314,087,555 | 261,864 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $221,241,468 | 240,540 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $269,413,693 | 250,692 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $186,287,976 | 244,152 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $197,973,330 | 253,965 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $203,713,996 | 246,654 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $201,356,128 | 260,824 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $236,388,274 | 266,822 | Shares | Defined | 2024-11-19 | |
| 2024-06-30 | $239,884,947 | 264,955 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $178,547,257 | 229,507 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $119,987,080 | 205,838 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $116,569,557 | 217,023 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $104,984,919 | 223,858 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $77,830,640 | 226,634 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $86,120,193 | 235,404 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $75,533,585 | 233,597 | Shares | Defined | 2022-11-17 | |
| 2022-09-30 | $1,293 | 4 | Call | Defined | 2022-11-17 | |
| 2022-06-30 | $74,800,505 | 230,702 | Shares | Defined | 2022-08-05 | |
| 2022-06-30 | $1,296 | 4 | Call | Defined | 2022-08-05 | |
| 2022-03-31 | $55,801,195 | 194,857 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $55,535,406 | 201,055 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $47,508,960 | 205,622 | Shares | Defined | 2021-10-28 | |
| 2021-06-30 | $47,944,658 | 208,891 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $38,596,071 | 206,595 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $36,775,374 | 217,812 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $33,591,359 | 226,938 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $37,576,530 | 228,874 | Shares | Defined | 2020-07-29 | |
| 2020-03-31 | $32,612,513 | 235,096 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||